| Year |
Citation |
Score |
| 2020 |
Papilloud A, Weger M, Bacq A, Zalachoras I, Hollis F, Larrieu T, Battivelli D, Grosse J, Zanoletti O, Parnaudeau S, Tronche F, Sandi C. The glucocorticoid receptor in the nucleus accumbens plays a crucial role in social rank attainment in rodents. Psychoneuroendocrinology. 112: 104538. PMID 31841985 DOI: 10.1016/J.Psyneuen.2019.104538 |
0.436 |
|
| 2018 |
Bacq A, Astori S, Gebara E, Tang W, Silva BA, Sanchez-Mut J, Grosse J, Guillot de Suduiraut I, Zanoletti O, Maclachlan C, Knott GW, Gräff J, Sandi C. Amygdala GluN2B-NMDAR dysfunction is critical in abnormal aggression of neurodevelopmental origin induced by St8sia2 deficiency. Molecular Psychiatry. PMID 30089788 DOI: 10.1038/S41380-018-0132-3 |
0.42 |
|
| 2015 |
Kohl C, Wang XD, Grosse J, Fournier C, Harbich D, Westerholz S, Li JT, Bacq A, Sippel C, Hausch F, Sandi C, Schmidt MV. Hippocampal neuroligin-2 links early-life stress with impaired social recognition and increased aggression in adult mice. Psychoneuroendocrinology. 55: 128-43. PMID 25765754 DOI: 10.1016/J.Psyneuen.2015.02.016 |
0.485 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Couroussé T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet AM, Gardier AM, Schinkel AH, Giros B, Gautron S. Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling. Molecular Psychiatry. 20: 889-900. PMID 25092247 DOI: 10.1038/Mp.2014.86 |
0.296 |
|
| 2012 |
Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres MP, Chevarin C, Hamon M, Giros B, Gautron S. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Molecular Psychiatry. 17: 926-39. PMID 21769100 DOI: 10.1038/Mp.2011.87 |
0.206 |
|
| 2024 |
Bacq A, Depaulis A, Castagné V, Le Guern ME, Wirrell EC, Verleye M. An Update on Stiripentol Mechanisms of Action: A Narrative Review. Advances in Therapy. 41: 1351-1371. PMID 38443647 DOI: 10.1007/s12325-024-02813-0 |
0.12 |
|
| 2023 |
Okoh J, Mays J, Bacq A, Oses-Prieto JA, Tyanova S, Chen CJ, Imanbeyev K, Doladilhe M, Zhou H, Jafar-Nejad P, Burlingame A, Noebels J, Baulac S, Costa-Mattioli M. Targeted suppression of mTORC2 reduces seizures across models of epilepsy. Nature Communications. 14: 7364. PMID 37963879 DOI: 10.1038/s41467-023-42922-y |
0.117 |
|
| 2018 |
Ribierre T, Deleuze C, Bacq A, Baldassari S, Marsan E, Chipaux M, Muraca G, Roussel D, Navarro V, Leguern E, Miles R, Baulac S. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy. The Journal of Clinical Investigation. PMID 29708508 DOI: 10.1172/Jci99384 |
0.115 |
|
| 2013 |
Nguyen HT, Guiard BP, Bacq A, David DJ, David I, Quesseveur G, Gautron S, Sanchez C, Gardier AM. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice. British Journal of Pharmacology. 168: 103-16. PMID 22233336 DOI: 10.1111/J.1476-5381.2012.01850.X |
0.056 |
|
| 2021 |
Bacq A, Roussel D, Bonduelle T, Zagaglia S, Maletic M, Ribierre T, Adle-Biassette H, Marchal C, Jennesson M, An I, Picard F, Navarro V, Sisodiya SM, Baulac S. Cardiac investigations in sudden unexpected death in DEPDC5-related epilepsy. Annals of Neurology. PMID 34693554 DOI: 10.1002/ana.26256 |
0.05 |
|
| Hide low-probability matches. |